Mayne Pharma
Kym Rispress has extensive work experience in the pharmaceutical industry. Kym is currently the owner of KR Pharma Consulting, a company they established in 2023. Before that, they worked at Mayne Pharma as the VP of Analytical Development for over 26 years. In this role, they managed an analytical development group and was responsible for various technical tasks related to product development. Prior to Mayne Pharma, Kym worked at Burroughs Wellcome as a Development Scientist III from 1992 to 1996, and at Roxane Labs as an Analytical Chemist from 1987 to 1992.
Kym Rispress earned a Bachelor of Arts (B.A.) degree in Chemistry from The Ohio State University between 1979 and 1984.
This person is not in any offices
Mayne Pharma
1 followers
Mayne Pharma Group Ltd is an Australia-based specialty pharmaceutical company. The Company is focused on commercializing branded and generic pharmaceuticals. It operates through four segments: Generic Products (GPD), Specialty Brands (SBD), Metrics Contract Services (MCS) and Mayne Pharma International (MPI). The GPD segment is engaged in the manufacture and distribution of generic pharmaceutical products in the United States. The SBD segment markets and distributes specialty branded pharmaceutical products in the United States. The MCS segment is engaged in the provision of contract analytical and pharmaceutical development services to third-party customers in the United States. The MPI segment is engaged in Australian manufacture and sale of branded and generic pharmaceutical product globally and provision of contract manufacturing services to third-party customers within Australia.